NEUARTIGE KALIUMKANALINHIBITOREN

Patent europeic · EP3419973 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3419973
Numer da la dumonda
EP17708164
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
23-02-2017
Publitgà
02-01-2019
Concedì
08-04-2020
La protecziun finescha il pli tard
22-02-2037
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
C07D 403/12 (2006.01)
C07D 401/12 (2006.01)
C07D 235/30 (2006.01)
C07D 405/12 (2006.01)
C07D 413/12 (2006.01)
C07D 417/12 (2006.01)
A61K 31/4188 (2006.01)
A61P 9/00 (2006.01)
Prioritad
EP 16020053 24.02.2016
Dumonda PCT
PCT/EP2017/025033 23.02.2017
Publicaziun PCT
WO2017/144183 31.08.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 06-03-2025

    Midada

    Published in Swissreg on 06.03.2025

  3. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  4. 06-03-2023

    Midada

    Published in Swissreg on 06.03.2023

  5. 15-04-2020

    Represchentant inscrit

    Representative
    TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly

    Published in Swissreg on 15.04.2020

  6. 08-04-2020

    Concedì

    Published in Swissreg on 08.04.2020

Partidas

Possessur

Acesion Pharma ApS

Ole Maaløes Vej 3, 2200 Copenhagen N, DK

Represchentant

TR-IP Consulting Sàrl

TR-IP Consulting LLC

Route du Coutset 18, 1485 Nuvilly

En liquidaziun

Inventur

METE, Antonio

Loughborough Leicestershire LE11 3LB, GB

SØRENSEN, Ulrik Svane

3500 Værløse, DK

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.